The Landscape of Actionable Genomic Alterations by Next-Generation Sequencing in Tumor Tissue Versus Circulating Tumor DNA in Chinese Patients With Non-Small Cell Lung Cancer

BACKGROUND: Circulating tumor DNA (ctDNA) sequence analysis shows great potential in the management of non-small cell lung cancer (NSCLC) and the prediction of drug sensitivity or resistance in many cancers. Here, we drew and compared the somatic mutational profile using ctDNA and tumor tissue seque...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Jun, Jiang, Huihui, Li, Shuqing, Yan, Xiaoxia, Wang, Meng, Li, Na, Zhu, Cuimin, Dong, Hui, Wang, Dongjuan, Xu, Yue, Xie, Hui, Wu, Shouxin, Lou, Jingwei, Zhao, Jiangman, Li, Qingshan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902245/
https://www.ncbi.nlm.nih.gov/pubmed/35273907
http://dx.doi.org/10.3389/fonc.2021.751106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902245/
https://www.ncbi.nlm.nih.gov/pubmed/35273907
http://dx.doi.org/10.3389/fonc.2021.751106

Ejemplares similares